Wednesday, July 8, 2026

pharma · Diabetes Mellitus · Hemophilia A

Takeda

Takeda is a pharma organization headquartered in Cambridge, USA. Primary therapeutic focus areas include Diabetes Mellitus, Hemophilia A, Crohn's Disease, Hypertension, Type 2 Diabetes Mellitus. NovaPharmaNews links 1179

Cambridge, USA HQ
1993 Founded
1,617 Employees
NMPA registrant Type
Company details
Clinical program

Colonoscopy

Unknown · other · CD

Colonoscopy for CD is a Unknown program (other) at Takeda with 2 ClinicalTrials.gov record(s).

← All Takeda projects Unknown other active

Internal code GETAID 2017-001

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Takeda
Phase
Unknown
Modality
other
Indication
CD
Status
active
Trials
2